M-CSF、β-Catenin因子在重度子痫前期患者血清中的表达及其临床意义

doi:10.3969/j.issn.1671-7171.2021.11.005

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1163 KB) HTML (0 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To explore the relationship between the expression of macrophage colony stimulating factor (M-CSF) and β-catenin (β-Catenin) in the serum of patients with severe pre-eclampsia (PE) and its clinical significance. 【Methods】There were 51 patients with early-onset severe PE and 51 cases of late-onset severe PE were selected in each group. The serum M-CSF and β-Catenin cytokine expression levels, clinical biochemical indicators and pregnancy complications were compared between the two groups, and their interaction relationship was analyzed. 【Results】 The expression levels of serum M-CSF and β-Catenin factor in the early-onset severe PE group were higher than those in the late-onset severe PE group, the difference was statistically significant (P<0.05). Pearson correlation analysis showed that the relationship of M-CSF and β-Catenin expression in the serum of patients with severe PE was significantly positively correlated (r=0.75, P=0.00＜0.01). The quantitative levels of serum creatinine (SCr), blood urea nitrogen (BUN), blood uric acid (UA) and 24h urine protein (24hpro) in patients with early-onset severe PE were significantly higher than those in patients with late-onset severe PE, and the differences were statistically significant ( P<0.05). The incidence of complications in the early-onset severe PE group was 78.43% (40/51), which was significantly higher than 35.29% (18/51) in the late-onset severe PE group, and the difference was statistically significant (χ²=10.77,P=0.02).【Conclusion】 The expression of serum M-CSF and β-Catenin in patients with severe preeclampsia plays a synergistic role in the pathogenesis of PE, and is closely related to the severity of the disease and the incidence of complications. Clinical diagnosis of severe PE needs to be confirmed as soon as possible, so active treatment measures can be put properly to improve pregnancy outcome.

Key words： Eclampsia/DI Macrophage Colony-Stimulating Factor/AN Proteins/AN

Received: 07 January 2021

PACS:

R714.245

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LIU Yan-yun
	YAN Xiao-yan
	LI Yun

Cite this article:

LIU Yan-yun,YAN Xiao-yan,LI Yun. Expression and Clinical Significance of M-CSF and β-Catenin in the Serum of Patients with Severe Preeclampsia[J]. JOURNAL OF CLINICAL RESEARCH, 2021, 38(11): 1618-1620.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2021.11.005 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2021/V38/I11/1618

[1] 王建六,古航,孙秀丽. 临床病例会诊与点评-妇产科分册[M].第1版.北京:人民军医出版社,2012:20-22.
[2] 钟惠,江英强,尹亚岚,等. 麻醉方式对胃癌患者术后呼吸道感染及淋巴细胞和应激水平的影响[J].中华医院感染学,2017,273(3):609-612.
[3] 王红玲. M-CSF与TNF-α 在早发型重度子痫前期胎盘组织中的表达水平及临床意义[D]. 郑州:河南科技大学,2019:5.
[4] 候敬,李斯宁,梁爽,等.血栓A2、AP-2α、ET-1及β-Catenin在子痫前期的意义和作用研究[J].国际检验医学,2018,39(22):2828-2830.
[5] 伦巍巍,朱建坡,张曦,等. 血红素氧化酶-2、巨噬细胞集落刺激因子在早发型重度子痫前期胎盘组织中的表达[J].中国现代药物应用,2016,10(13):46-47.
[6] 郝丽英,李扬,刘琴,等. 重度子痫前期胎盘的免疫组化改变与围产儿预后的关系[J].中国妇幼保健,2017,22(5):654-656.
[7] 刘力,张敬蕊,候晓琳.重度子痫前期患者血清生长抑制特异性蛋白6水平与病情严重程度的相关性研究[J].检验医学与临床,2019,16(23):3447-3449.
[8] 王东东. 血清IL -33在子痫前期患者中的表达及临床意义[J].实验与检验医学,2020,38(4):717-718.
[9] 康倩. 妊娠糖尿病患者血清促代谢因子水平与血脂、胰岛素抵抗指数及胰岛β细胞功能指数相关性[J].医学临床研究,2019,36(3):532-534.
[10] Kumar A, Begum N, Prasad S, et al.IL-10,TNF-α＆ IFN-γ:Potential early biomarkers for preeclampsia[J].Cell Immunol,2016, 283(1-2):70-74.
[11] 张素萍,王杏芹,周冰霞,等. TNF-α在子痫前期胎盘中表达的临床研究[J].中国临床医生,2017,24(5):69-71.
[12] 张文涛,赵妙香. 炎性因子在糖尿病周围神经病变患者血清中的表达及其与神经传导速度的相关性分析[J].医学临床研究,2021,38(5):769-771.
[13] 常春玲,孙鸿,林林,等.早发型重度子痫前期患者应用拉贝洛尔治疗对母婴结局以及PT、F9等的影响[J].检验医学与临床,2017,14(1):94-97.
[14] 任艳芳. 早发型子痫前期孕妇出现不良妊娠结局与血清胱抑素c水平的相关性研究[J].中国妇幼保健, 2015,30(26):4446-4448.
[15] 彭静,杨柳.炎性反应及血管生成相关指标与子痫前期相关性研究[J].检验医学与临床,2016,13(13):1870-1872.